No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract CARDAMON case series: Thrombotic microangiopathy in newly diagnosed multiple myeloma patients receiving carfilzomib, cyclophosphamide, and dexamethasone can be preventatively managed

byKathleen Lau

March 25, 2021

in StudyGraphics

Reinfection rates among patients previously testing positive for COVID-19

RelatedReports

Patients with advanced adenomas are at increased risk of developing colorectal cancer

AI Roundup

AstraZeneca moves to own multimodal oncology AI with Modella

January 21, 2026

AI Roundup

2MM: AI Roundup – Lilly and NVIDIA’s $1B AI lab, Illumina’s Billion Cell Atlas, AstraZeneca’s Modella deal, and Claude for Healthcare [Jan 19th, 2026]

January 19, 2026

Remote patient monitoring did not reduce heart failure readmissions: The BEAT-HF trial

Weekly Rewinds

2 Minute Medicine Rewind

January 13, 2026

Testosterone replacement in male cancer survivors helps improve body composition

Oncology

New model enhances prediction of prostate cancer-specific mortality

January 12, 2026

#VisualAbstract: Early discontinuation of endocrine therapy may increase risk of breast cancer recurrence in premenopausal women

#VisualAbstract: BRAF and MEK inhibitor combination therapy shows efficacy for advanced melanoma in Japanese patients

#VisualAbstract Brief pembrolizumab monotherapy followed by doxorubicin, vinblastine, and dacarbazine was both effective and safe in untreated early unfavourable and advanced stage classical Hodgkin lymphoma

Colchicine may lower the risk of cardiovascular events in patients with coronary disease

Non-obstructive lesions with high lipid content may increase risk for future adverse cardiac outcomes

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports